MX385379B - Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilciclohexanol e intermedios utiles en este. - Google Patents
Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilciclohexanol e intermedios utiles en este.Info
- Publication number
- MX385379B MX385379B MX2020001720A MX2020001720A MX385379B MX 385379 B MX385379 B MX 385379B MX 2020001720 A MX2020001720 A MX 2020001720A MX 2020001720 A MX2020001720 A MX 2020001720A MX 385379 B MX385379 B MX 385379B
- Authority
- MX
- Mexico
- Prior art keywords
- garment
- amino
- methods
- region
- useful
- Prior art date
Links
- HKWIETGWMFZMPJ-RYLOHDEPSA-N (1r,2r,5r)-5-amino-2-methylcyclohexan-1-ol;hydrochloride Chemical compound Cl.C[C@@H]1CC[C@@H](N)C[C@H]1O HKWIETGWMFZMPJ-RYLOHDEPSA-N 0.000 title abstract 3
- 239000000543 intermediate Substances 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 230000006835 compression Effects 0.000 abstract 4
- 238000007906 compression Methods 0.000 abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 210000001624 hip Anatomy 0.000 abstract 2
- 230000037361 pathway Effects 0.000 abstract 2
- 230000000399 orthopedic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/54—Preparation of compounds containing amino groups bound to a carbon skeleton by rearrangement reactions
- C07C209/58—Preparation of compounds containing amino groups bound to a carbon skeleton by rearrangement reactions from or via amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/82—Purification; Separation; Stabilisation; Use of additives
- C07C209/86—Separation
- C07C209/88—Separation of optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C67/347—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562196363P | 2015-07-24 | 2015-07-24 | |
| PCT/US2016/043511 WO2017019487A1 (en) | 2015-07-24 | 2016-07-22 | Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2020001720A MX2020001720A (es) | 2021-08-13 |
| MX385379B true MX385379B (es) | 2025-03-18 |
Family
ID=57885143
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020001720A MX385379B (es) | 2015-07-24 | 2016-07-22 | Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilciclohexanol e intermedios utiles en este. |
| MX2018001004A MX2018001004A (es) | 2015-07-24 | 2016-07-22 | Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilci clohexanol e intermedios utiles en este. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018001004A MX2018001004A (es) | 2015-07-24 | 2016-07-22 | Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilci clohexanol e intermedios utiles en este. |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US10252981B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3325432B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6805232B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107922287B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2016297784B2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3208587A1 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2819374T3 (cg-RX-API-DMAC7.html) |
| MX (2) | MX385379B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017019487A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016123291A1 (en) | 2015-01-29 | 2016-08-04 | Signal Pharmaceuticals, Llc | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
| CA3208587A1 (en) | 2015-07-24 | 2017-02-02 | Celgene Corporation | Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein |
| CN111848423B (zh) * | 2019-04-30 | 2022-10-14 | 尚科生物医药（上海）有限公司 | 3-氧代环丁基氨基甲酸叔丁酯的制备方法 |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2859239A (en) * | 1956-08-17 | 1958-11-04 | Dow Chemical Co | Acrylic acid compounds |
| CH549339A (de) | 1971-05-12 | 1974-05-31 | Ciba Geigy Ag | Herbizides mittel. |
| US5763647A (en) * | 1990-03-30 | 1998-06-09 | Shionogi & Co., Ltd. | Preparation of optically active 1,4-bridged-cyclohexane carboxylic acid derivatives |
| CA2072270A1 (en) * | 1991-06-26 | 1992-12-27 | Joseph V. Koleske | Production of unsaturated cycloaliphatic esters and derivatives thereof |
| WO1999031073A1 (en) | 1997-12-15 | 1999-06-24 | Yamanouchi Pharmaceutical Co., Ltd. | Novel pyrimidine-5-carboxamide derivatives |
| JP2002523497A (ja) | 1998-08-29 | 2002-07-30 | アストラゼネカ・アクチエボラーグ | ピリミジン化合物 |
| US6797706B1 (en) | 1999-06-09 | 2004-09-28 | Yamanouchi Pharmaceutical Co., Ltd. | Heterocyclecarboxamide derivative |
| AU5108000A (en) | 1999-06-10 | 2001-01-02 | Yamanouchi Pharmaceutical Co., Ltd. | Novel nitrogen-contaiing heterocyclic derivatives or salts thereof |
| WO2001000213A1 (en) | 1999-06-30 | 2001-01-04 | Merck & Co., Inc. | Src kinase inhibitor compounds |
| CN1222520C (zh) | 1999-08-12 | 2005-10-12 | 沃泰克斯药物股份有限公司 | c－JUN N－末端激酶(JNK)和其它蛋白激酶的抑制剂 |
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| GB0206215D0 (en) | 2002-03-15 | 2002-05-01 | Novartis Ag | Organic compounds |
| JPWO2003082855A1 (ja) | 2002-03-28 | 2005-08-04 | 協和醗酵工業株式会社 | 抗炎症剤 |
| US7449456B2 (en) | 2002-06-28 | 2008-11-11 | Astellas Pharma, Inc. | Diaminopyrimidinecarboxamide derivative |
| BR0313059B8 (pt) | 2002-07-29 | 2021-07-27 | Rigel Pharmaceuticals | composto, e, composição farmacêutica |
| JPWO2004054617A1 (ja) | 2002-12-13 | 2006-04-20 | 協和醗酵工業株式会社 | 中枢疾患の予防および／または治療剤 |
| JP4392661B2 (ja) * | 2003-01-16 | 2010-01-06 | 東レ・ファインケミカル株式会社 | 光学活性ジアシル酒石酸の回収方法 |
| WO2004065378A1 (en) | 2003-01-17 | 2004-08-05 | Warner-Lambert Company Llc | 2-aminopyridine substituted heterocycles as inhibitors of cellular proliferation |
| EP1590334B1 (en) | 2003-01-30 | 2009-08-19 | Boehringer Ingelheim Pharmaceuticals Inc. | 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| SI2287156T1 (sl) | 2003-08-15 | 2013-09-30 | Novartis Ag | 2,4-di(fenilamino)-pirimidini, uporabni pri zdravljenju neoplastičnih bolezni, vnetnih motenj in motenj imunskega sistema |
| CN1871009A (zh) | 2003-09-24 | 2006-11-29 | 惠氏控股公司 | 作为抗癌剂的5－芳基嘧啶 |
| WO2005095382A1 (ja) | 2004-03-30 | 2005-10-13 | Kyowa Hakko Kogyo Co., Ltd. | 抗腫瘍剤 |
| JP2008505910A (ja) | 2004-07-08 | 2008-02-28 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | Ｐｋｃ−シータのインヒビターとして有用なピリミジン誘導体 |
| WO2006027377A1 (en) | 2004-09-10 | 2006-03-16 | Altana Pharma Ag | Ciclesonide and syk inhibitor combination and methods of use thereof |
| EP1791538A1 (en) | 2004-09-10 | 2007-06-06 | Altana Pharma AG | Roflumilast and syk inhibitor combination and methods of use thereof |
| JP2006124387A (ja) | 2004-09-30 | 2006-05-18 | Taisho Pharmaceut Co Ltd | 新規なキノリン、テトラヒドロキナゾリン、及びピリミジン誘導体と、これらを使用することに関連した治療方法 |
| RU2410379C2 (ru) | 2004-09-30 | 2011-01-27 | Тиботек Фармасьютикалз Лтд. | 5-замещенные пиримидины, ингибирующие вич |
| WO2006091737A1 (en) | 2005-02-24 | 2006-08-31 | Kemia, Inc. | Modulators of gsk-3 activity |
| US20110098301A1 (en) | 2005-03-10 | 2011-04-28 | Bayer Healthcare Llc | Pyrimidine Derivatives for Treatment of Hyperproliferative Disorders |
| WO2007032445A1 (ja) | 2005-09-16 | 2007-03-22 | Kyowa Hakko Kogyo Co., Ltd. | タンパク質キナーゼ阻害剤 |
| JP2009544592A (ja) | 2006-07-21 | 2009-12-17 | ノバルティス アクチエンゲゼルシャフト | Ｊａｋキナーゼ阻害剤としての２，４−ジ（アリールアミノ）−ピリミジン−５−カルボキサミド化合物 |
| US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| US20080139531A1 (en) | 2006-12-04 | 2008-06-12 | Alcon Manufacturing Ltd. | Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair |
| CL2007003693A1 (es) * | 2006-12-22 | 2008-06-27 | Actelion Pharmaceuticals Ltd | Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas. |
| JP4782239B2 (ja) | 2007-04-18 | 2011-09-28 | ファイザー・プロダクツ・インク | 異常細胞増殖治療のためのスルホニルアミド誘導体 |
| CA2687943A1 (en) | 2007-04-27 | 2008-11-06 | Astrazeneca Ab | N'-(phenyl)-n-(morpholin-4-yl-pyridin-2-yl)-pyrimidine-2,4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions |
| BRPI0814821A2 (pt) | 2007-07-16 | 2015-02-03 | Astrazeneca Ab | Composto, composição farmacêutica, e, processo para preparar um composto |
| BRPI0814432A2 (pt) | 2007-07-17 | 2017-05-09 | Rigel Pharmaceuticals Inc | pirimidinadiaminas substituídas por amina cíclica como inibidores de pkc |
| JP5269444B2 (ja) * | 2008-03-11 | 2013-08-21 | 東ソー・ファインケム株式会社 | 固体ルイス酸触媒、それを用いたディールスアルダー付加物の製造方法 |
| CA2960692C (en) | 2008-04-16 | 2019-09-24 | Portola Pharmaceuticals, Inc. | 2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinase inhibitors |
| SG2014015085A (en) | 2008-04-16 | 2014-06-27 | Portola Pharm Inc | 2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors |
| EP2271631B1 (en) | 2008-04-22 | 2018-07-04 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
| EP2280969A1 (en) | 2008-04-29 | 2011-02-09 | F. Hoffmann-La Roche AG | Pyrimidinyl pyridone inhibitors of jnk. |
| PL2300013T5 (pl) | 2008-05-21 | 2025-04-28 | Takeda Pharmaceutical Company Limited | Pochodne fosforu jako inhibitor kinazy |
| UY31929A (es) | 2008-06-25 | 2010-01-05 | Irm Llc | Compuestos y composiciones como inhibidores de cinasa |
| CA2986640C (en) | 2008-06-27 | 2019-03-26 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
| US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
| EP2325175A4 (en) | 2008-09-01 | 2012-03-21 | Astellas Pharma Inc | 2,4-DIAMINOPYRIMIDINVERBINDUNG |
| EP2159220A1 (en) * | 2008-09-02 | 2010-03-03 | Nabriva Therapeutics AG | Organic compounds |
| TWI453207B (zh) * | 2008-09-08 | 2014-09-21 | Signal Pharm Llc | 胺基三唑并吡啶，其組合物及使用其之治療方法 |
| KR20110060894A (ko) | 2008-09-18 | 2011-06-08 | 아스테라스 세이야쿠 가부시키가이샤 | 복소환 카르복사미드 화합물 |
| TW201016676A (en) | 2008-10-03 | 2010-05-01 | Astrazeneca Ab | Heterocyclic derivatives and methods of use thereof |
| CN102272291B (zh) | 2008-10-31 | 2018-01-16 | 詹森生物科技公司 | 人胚胎干细胞向胰腺内分泌谱系的分化 |
| US8513242B2 (en) | 2008-12-12 | 2013-08-20 | Cystic Fibrosis Foundation Therapeutics, Inc. | Pyrimidine compounds and methods of making and using same |
| JP5683489B2 (ja) | 2009-01-12 | 2015-03-11 | アレイ バイオファーマ、インコーポレイテッド | ピペリジン含有化合物およびその用途 |
| ES2433109T3 (es) | 2009-01-13 | 2013-12-09 | Glaxo Group Limited | Derivados de pirimidin-carboxamida como inhibidores de la Syk cinasa |
| EP2389373B1 (en) | 2009-01-21 | 2017-05-17 | Rigel Pharmaceuticals, Inc. | Derivatives of n2-(3-pyridyl or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases |
| AR076550A1 (es) | 2009-05-06 | 2011-06-22 | Portola Pharm Inc | Inhibidores de la janus tirosina kinasa (jak) |
| WO2010128659A1 (ja) | 2009-05-08 | 2010-11-11 | アステラス製薬株式会社 | ジアミノへテロ環カルボキサミド化合物 |
| JP2012148977A (ja) | 2009-05-20 | 2012-08-09 | Astellas Pharma Inc | アミノシクロヘキシルアルキル基を有する２，４−ジアミノピリミジン化合物 |
| MX2011013325A (es) | 2009-06-10 | 2012-04-30 | Abbott Lab | 2-(lh-pirazol-4-ilamino)-pirimidina como inhibidores de cinasa. |
| JP2012197231A (ja) | 2009-08-06 | 2012-10-18 | Oncotherapy Science Ltd | Ｔｔｋ阻害作用を有するピリジンおよびピリミジン誘導体 |
| WO2011065800A2 (ko) | 2009-11-30 | 2011-06-03 | 주식회사 오스코텍 | 피리미딘 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물 |
| CA2780759A1 (en) | 2009-12-01 | 2011-06-09 | Rigel Pharmaceuticals, Inc. | Protein kinase c inhibitors and uses thereof |
| EP2582671A4 (en) * | 2010-06-17 | 2014-02-26 | Reddys Lab Ltd Dr | PROCESS FOR PREPARING A SINGLE ENANTIOMER FROM 3-AMINOPIPERIDIN DIHYDROCHLORIDE |
| US8710223B2 (en) | 2010-07-21 | 2014-04-29 | Rigel Pharmaceuticals, Inc. | Protein kinase C inhibitors and uses thereof |
| US8580805B2 (en) | 2010-08-31 | 2013-11-12 | Hubert Maehr | Pyrimidine carboxamide derivatives |
| US20130244963A1 (en) | 2010-09-30 | 2013-09-19 | Portola Pharmaceuticals, Inc. | Combination therapy with 4-(3-(2h-1,2,3-triazol-2-yl)phenylamino)-2-((1r,2s)-2-aminocyclohexylamino)pyrimidine-5-carboxamide |
| EP2621489A1 (en) | 2010-09-30 | 2013-08-07 | Portola Pharmaceuticals, Inc. | Combinations of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine |
| FI2699553T3 (fi) * | 2011-04-22 | 2024-01-24 | Signal Pharm Llc | Substituoituja diaminokarboksamidi- ja diaminokarbonitriilipyrimidiinejä, niiden koostumuksia ja niitä käyttäviä hoitomenetelmiä |
| WO2014019166A1 (zh) * | 2012-08-01 | 2014-02-06 | 上海威智医药科技有限公司 | 高活性硼烷类化合物的工业化生产方法 |
| JP2014031327A (ja) * | 2012-08-02 | 2014-02-20 | Kaneka Corp | 光学活性シス−２−アミノ−シクロヘキサンカルボン酸誘導体およびその前駆体の製造法 |
| RU2016129380A (ru) | 2013-12-20 | 2018-01-25 | СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Замещенные диаминопиримидильные соединения, их композиции и способы лечения с их участием |
| NZ715903A (en) * | 2014-01-30 | 2017-06-30 | Signal Pharm Llc | Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use |
| TWI523838B (zh) * | 2014-03-21 | 2016-03-01 | Far Eastern New Century Corp | Terephthalic acid and 4-methyl-3-cyclohexene-1-carboxylic acid Ester preparation method |
| ES2980464T3 (es) | 2014-10-06 | 2024-10-01 | Signal Pharm Llc | Productos intermedios sintéticos útiles para preparar compuestos de aminopurina sustituidos |
| US9513297B2 (en) | 2014-12-16 | 2016-12-06 | Signal Pharmaceuticals, Llc | Methods for measurement of inhibition of c-Jun N-terminal kinase in skin |
| KR102606253B1 (ko) | 2014-12-16 | 2023-11-27 | 시그날 파마소티칼 엘엘씨 | 2-(tert-부틸아미노)-4-((1r,3r,4r)-3-하이드록시-4-메틸사이클로헥실아미노)-피리미딘-5-카복사마이드의 제형 |
| WO2016123291A1 (en) | 2015-01-29 | 2016-08-04 | Signal Pharmaceuticals, Llc | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
| CA3208587A1 (en) * | 2015-07-24 | 2017-02-02 | Celgene Corporation | Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein |
-
2016
- 2016-07-22 CA CA3208587A patent/CA3208587A1/en active Pending
- 2016-07-22 CA CA2993173A patent/CA2993173C/en active Active
- 2016-07-22 CN CN201680043308.1A patent/CN107922287B/zh active Active
- 2016-07-22 EP EP16831114.0A patent/EP3325432B1/en active Active
- 2016-07-22 AU AU2016297784A patent/AU2016297784B2/en active Active
- 2016-07-22 JP JP2018503482A patent/JP6805232B2/ja active Active
- 2016-07-22 ES ES16831114T patent/ES2819374T3/es active Active
- 2016-07-22 US US15/746,853 patent/US10252981B2/en active Active
- 2016-07-22 ES ES20193348T patent/ES2994877T3/es active Active
- 2016-07-22 EP EP20193348.8A patent/EP3795553B1/en active Active
- 2016-07-22 MX MX2020001720A patent/MX385379B/es unknown
- 2016-07-22 MX MX2018001004A patent/MX2018001004A/es active IP Right Grant
- 2016-07-22 WO PCT/US2016/043511 patent/WO2017019487A1/en not_active Ceased
-
2019
- 2019-01-28 US US16/258,802 patent/US10774033B2/en active Active
-
2020
- 2020-08-13 US US16/992,219 patent/US11192847B2/en active Active
- 2020-12-03 JP JP2020200723A patent/JP7165178B2/ja active Active
-
2021
- 2021-03-09 AU AU2021201493A patent/AU2021201493B2/en active Active
- 2021-11-03 US US17/518,552 patent/US11780801B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021046426A (ja) | 2021-03-25 |
| EP3795553B1 (en) | 2024-05-15 |
| JP2018521085A (ja) | 2018-08-02 |
| US11192847B2 (en) | 2021-12-07 |
| US20220234990A1 (en) | 2022-07-28 |
| US11780801B2 (en) | 2023-10-10 |
| CA2993173C (en) | 2023-10-03 |
| AU2021201493B2 (en) | 2022-07-14 |
| EP3325432A4 (en) | 2019-04-24 |
| EP3325432A1 (en) | 2018-05-30 |
| US10252981B2 (en) | 2019-04-09 |
| US20190152893A1 (en) | 2019-05-23 |
| AU2016297784A1 (en) | 2018-02-08 |
| MX2020001720A (es) | 2021-08-13 |
| US20200369600A1 (en) | 2020-11-26 |
| US20180215700A1 (en) | 2018-08-02 |
| CN107922287B (zh) | 2021-04-09 |
| MX2018001004A (es) | 2018-06-07 |
| CA2993173A1 (en) | 2017-02-02 |
| HK1255553A1 (en) | 2019-08-23 |
| AU2016297784B2 (en) | 2020-12-24 |
| AU2021201493A1 (en) | 2021-03-25 |
| EP3325432B1 (en) | 2020-09-02 |
| EP3795553A1 (en) | 2021-03-24 |
| CA3208587A1 (en) | 2017-02-02 |
| JP6805232B2 (ja) | 2020-12-23 |
| ES2994877T3 (en) | 2025-02-03 |
| CN107922287A (zh) | 2018-04-17 |
| ES2819374T3 (es) | 2021-04-15 |
| US10774033B2 (en) | 2020-09-15 |
| JP7165178B2 (ja) | 2022-11-02 |
| WO2017019487A1 (en) | 2017-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022004678A (es) | Anticuerpo anti-beta amiloide para el tratamiento de la enfermedad de alzheimer. | |
| CA193736S (en) | Skin massager | |
| PH12022550886A1 (en) | INHIBITING HUMAN INTEGRIN a4Ã7 | |
| CY1124243T1 (el) | Αναστολη του ιοντικου διαυλου υποδοχεα παροδικου δυναμικου α1 | |
| MX2016004030A (es) | Inhibidores sustituidos de nicotinamida de btk y su preparacion y uso en el tratamiento del cancer, inflamacion y enfermedad autoinmune. | |
| MX2015009773A (es) | Moduladores de receptores nmda de espiro-lactama y sus usos. | |
| PH12015501601A1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| PH12015501596B1 (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| CL2018003431A1 (es) | Tratamiento de la enfermedad de parkinson. | |
| MX2015009778A (es) | Moduladores de receptores nmda de espiro-lactama y sus usos. | |
| EA201791802A1 (ru) | СШИТЫЕ ДИГИДРО-4H-ПИРАЗОЛО[5,1-c][1,4]ОКСАЗИНИЛОВЫЕ СОЕДИНЕНИЯ И АНАЛОГИ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ЦНС | |
| MX393879B (es) | Métodos de preparación de niraparib. | |
| MX2020001720A (es) | Metodos de sintesis de clorhidrato de (1r,2r,5r)-5-amino-2-metilci clohexanol e intermedios utiles en este. | |
| CL2020001290A1 (es) | Método para el tratamiento de enfermedades gastrointestinales con tradipitant. | |
| MX2019008546A (es) | Usos terapeuticos de un polvo de insectos. | |
| UA122873C2 (uk) | Контрацептивний засіб на основі дроспіренону для пацієнтки, що страждає від надлишкової маси тіла | |
| CR20210442A (es) | ALCOHOLES TERCIARIOS COMO INHIBIDORES DE PI3K-y (Divisional Exp. 2020-0214) | |
| JOP20190233A1 (ar) | نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون | |
| MX2019005040A (es) | Métodos y composiciones para prevenir la transmisión de enfermedades vectoriales. | |
| IL285870A (en) | Leucine, acetyl leucine, and related analogs for treating disease | |
| CL2020001131A1 (es) | Administración oral de análogos del péptido glp-1. | |
| EA201792469A1 (ru) | Циклические соединения | |
| PH12019501785B1 (en) | Intranasal composition comprising betahistine | |
| FR3075012B1 (fr) | Procede de traitement cosmetique par plasma froid | |
| CR20220006A (es) | Compuestos para tratar enfermedad respiratoria |